@article{Zambrano Olave_Gamarra Contreras_2021, title={FACTORES ASOCIADOS A SEVERIDAD Y MORTALIDAD POR COVID-19 EN PACIENTES CON DIABETES MELLITUS HOSPITALIZADOS; HOSPITAL REGIONAL DEL CUSCO 2020-2021}, volume={24}, url={https://revistas.unsaac.edu.pe/index.php/SITUA/article/view/807}, DOI={10.51343/si.v24i2.807}, abstractNote={<p>RESUMEN<br>Antecedentes: Ciertas enfermedades infecciosas tienen mayor frecuencia y severidad<br>en pacientes con diabetes, siendo esta una de las comorbilidades más frecuentes de la<br>enfermedad de COVID-19, esta debido a que produce un proceso inflamatorio crónico.<br>Métodos: Estudio de casos y controles, analítico, retrospectivo y transversal, el objetivo<br>fue determinar los factores asociados a severidad y mortalidad por COVID-19 en<br>pacientes con diabetes mellitus, se utilizó a toda la población conformada por 76<br>pacientes, de los cuales se hallo 30 casos y 30 controles que cumplian con los criterios<br>de inclusión, se reviso histórias. Resultados: La mortalidad estuvo asociada a HTA (<br>OR: 1.87; p=0.014; IC 95% [1.14-3.09], dislipidemia (OR: 2.36; p=0.008; [1.25-4.47]),<br>tiempo de evolución de diabetes ≥ 5 años (OR:2.46; p=0.006; IC 95%[1.29-4.70]), nivel<br>de hemoglobina glicosilada entre 7-8.9% (OR:6.61;p=0.000;IC 95% [2.87-15.22] y un<br>nivel ≥9% (OR:3.18; p=0.003; IC95% [1.48-6.81], nivel elevado de PCR (p=0.000) y nivel<br>elevado de LDH(p=0.038) y la severidad estuvo asociada a la severidad estuvo asociada<br>a HTA (OR:1.69; p=0.029; IC 95% [1.06-2.69]), dislipidemia (OR:1.84; p=0.022; IC 95%<br>[1.09-3.10]), nivel de hemoglobina glicosilada entre 7-8.9% (OR:3.03; p=0.014; IC 95%<br>[1.26-7.31], nivel elevado de glucosa al ingreso (p=0.016), nivel elvado de PCR(p=0.012).<br>Conclusiones: En conclusión se debe prestar especial atención en pacientes con<br>diabetes y COVID-19 que presenten HTA, dislipidemia, tiempo de evolución de diabetes<br>≥ 5 años, nivel elevado de hemoglobina glicosilada, PCR y LDH.<br>Palabras claves: Factores asociados, diabetes mellitus, SARS-CoV-2, mortalidad,<br>enfermedad crítica, muerte por covid-19. [DeCS/MeSH]<br>SUMMARY<br>Background: Certain infectious diseases are more frequent and severe in patients with<br>diabetes, this being one of the most frequent comorbidities of the COVID-19 disease, due<br>to the fact that it produces a chronic inflammatory process. Methods: Analytical,<br>retrospective and cross-sectional case-control study, the objective was to determine the<br>factors associated with severity and mortality due to COVID-19 in patients with diabetes<br>mellitus, the entire population consisting of 76 patients was used, of which 30 were found.<br>cases and 30 controls that met the inclusion criteria, histories were reviewed. Results:<br>Mortality was associated with hypertension (OR: 1.87; p = 0.014; 95% CI [1.14-3.09],<br>dyslipidemia (OR: 2.36; p = 0.008; [1.25-4.47]), time of evolution of diabetes ≥ 5 years ( <br>OR: 2.46; p = 0.006; 95% CI [1.29-4.70]), glycosylated hemoglobin level between 7-8.9%<br>(OR: 6.61; p = 0.000; 95% CI [2.87-15.22] and a level ≥9% (OR: 3.18; p = 0.003; 95% CI<br>[1.48-6.81], high level of CRP (p = 0.000) and high level of LDH (p = 0.038) and severity<br>was associated with severity was associated with hypertension (OR : 1.69; p = 0.029;<br>95% CI [1.06-2.69]), dyslipidemia (OR: 1.84; p = 0.022; 95% CI [1.09-3.10]), glycosylated<br>hemoglobin level between 7-8.9% (OR: 3.03 ; p = 0.014; 95% CI [1.26-7.31], elevated<br>glucose level upon admission (p = 0.016), elevated CRP level (p = 0.012). Conclusions:<br>In conclusion, special attention should be paid to patients with diabetes and COVID-19<br>who present with hypertension, dyslipidemia, time of evolution of diabetes ≥ 5 years,<br>elevated level of glycosylated hemoglobin, CRP and LDH.<br>Key words: Associated factors, diabetes mellitus, SARS-CoV-2, mortality, critical<br>illness, death from covid-19. [DeCS/MeSH]</p&gt;}, number={2}, journal={SITUA}, author={Zambrano Olave, Mindy and Gamarra Contreras, Marco}, year={2021}, month={oct.} }